Concepedia

Keith E. Kelly

KE

Statistics

Publications

3

Citations

90

H-Index

3

Active since

1998

Affiliations

Autoimmune Technologies (United States)(Current)

Keith E. Kelly is an author at Autoimmune Technologies (United States) specializing in lung cancer, radiation oncology, and cancer therapeutics.

Top concepts

Publications per year

1998–2005

3

Publications

3

T-CELL AND MAJOR HISTOCOMPATIBILITY COMPLEX REQUIREMENTS FOR OBLITERATIVE AIRWAY DISEASE IN HETEROTOPICALLY TRANSPLANTED MURINE TRACHEAS1

Keith E. Kelly, Marshall I. Hertz, Daniel L. Mueller · Transplantation · 1998 · 62 citations

P-460 Results of a phase 2 trial of HGS-ETR1 (agonistic humanmonoclonal antibody to TRAIL receptor 1) in subjects with relapsedlrecurrent non-small cell lung cancer (NSCLC)

P. Bonomi, F. Anthony Greco, J. Crawford et al. · Lung Cancer · 2005 · 15 citations

, , +9

Efficacy and safety of gefitinib (Iressa, ZD1839), an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with advanced non-small cell lung cancer

MG Kris, Natale Rb, R. Herbst et al. · 2003 · 13 citations

, , +5

1–3 of 3